Related references
Note: Only part of the references are listed.Bone morphogenetic protein receptors and signal transduction
Kohei Miyazono et al.
JOURNAL OF BIOCHEMISTRY (2010)
Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
Xiang H. -F. Zhang et al.
CANCER CELL (2009)
Single-vector inducible lentiviral RNAi system for oncology target validation
Dmitri Wiederschain et al.
CELL CYCLE (2009)
The M-type receptor PLA2R regulates senescence through the p53 pathway
Arnaud Augert et al.
EMBO REPORTS (2009)
The Increasing Complexity of the Cancer Stem Cell Paradigm
Jeffrey M. Rosen et al.
SCIENCE (2009)
Signal integration by JNK and p38 MAPK pathways in cancer development
Erwin F. Wagner et al.
NATURE REVIEWS CANCER (2009)
p21 in cancer: intricate networks and multiple activities
Tarek Abbas et al.
NATURE REVIEWS CANCER (2009)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer
Liudmila L. Kodach et al.
CANCER (2008)
Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence
Stephane Ansieau et al.
CANCER CELL (2008)
Systemic endocrine instigation of indolent tumor growth requires osteopontin
Sandra S. McAllister et al.
CELL (2008)
Zeb1 links epithelial-mesenchymal transition and cellular senescence
Yongqing Liu et al.
DEVELOPMENT (2008)
The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers
Liudmila L. Kodach et al.
GASTROENTEROLOGY (2008)
Metastasis: a therapeutic target for cancer
Patricia S. Steeg et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states
Thomas P. Ellen et al.
CARCINOGENESIS (2008)
Models, mechanisms and clinical evidence for cancer dormancy
Julio A. Aguirre-Ghiso
NATURE REVIEWS CANCER (2007)
Bone morphogenetic protein 7 in the development and treatment of bone Metastases from breast cancer
Jeroen T. Buijs et al.
CANCER RESEARCH (2007)
Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists
Lin Ye et al.
JOURNAL OF UROLOGY (2007)
The pathways to tumor suppression via route p38
Jiahuai Han et al.
TRENDS IN BIOCHEMICAL SCIENCES (2007)
RhBMP-7 accelerates the healing in distal tibial fractures treated by external fixation
J. Ristiniemi et al.
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2007)
PRAK is essential for ras-induced senescence and tumor suppression
Peiqing Sun et al.
CELL (2007)
p38 alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation
Juan Jose Ventura et al.
NATURE GENETICS (2007)
The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer
Sucharita Bandyopadhyay et al.
CANCER RESEARCH (2006)
Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogen-activated protein Kinase/Sp1-mediated activation of two GC-rich promoter elements
Arvind Dasari et al.
CANCER RESEARCH (2006)
Basic mechanisms responsible for osteolytic and osteoblastic bone metastases
Theresa A. Guise et al.
CLINICAL CANCER RESEARCH (2006)
Gadd45a suppresses ras-driven mammary tumorigenesis by activation of c-Jun NH2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence
Jennifer S. Tront et al.
CANCER RESEARCH (2006)
Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis
Yuichiro Maruyama et al.
CANCER RESEARCH (2006)
Telomerase activity in disseminated prostate cancer cells
Jesco Pfitzenmaier et al.
BJU INTERNATIONAL (2006)
The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma
JA Hickson et al.
CANCER RESEARCH (2006)
Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma
T. Ando et al.
DISEASES OF THE ESOPHAGUS (2006)
Gonadotropin-releasing hormone agonists and fracture risk: A claims-based cohort study of men with nonmetastatic prostate cancer
MR Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Bone morphogenetic proteins in vascular calcification
KA Hruska et al.
CIRCULATION RESEARCH (2005)
Gene expression profiling predicts clinical outcome of prostate cancer
GV Glinsky et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression
S Bandyopadhyay et al.
ONCOGENE (2004)
Integrin α5β1 promotes survival of growth-arrested breast cancer cells:: An in vitro paradigm for breast cancer dormancy in bone marrow
R Korah et al.
CANCER RESEARCH (2004)
Stromal fibroblasts in cancer initiation and progression
NA Bhowmick et al.
NATURE (2004)
Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1
IY Kim et al.
CANCER RESEARCH (2004)
Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth
JA Aguirre-Ghiso et al.
CANCER RESEARCH (2004)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
Reversal of human cellular senescence:: roles of the p53 and p16 pathways
CM Beauséjour et al.
EMBO JOURNAL (2003)
The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc
J Li et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
J Sage et al.
NATURE (2003)
BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury
M Zeisberg et al.
NATURE MEDICINE (2003)
Reversal of senescence in mouse fibroblasts through lentiviral in suppression of p53
AMG Dirac et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Age-related changes in cartilage endogenous osteogenic protein-1 (OP-1)
S Chubinskaya et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
Metastatic prostate carcinoma to bone - Clinical and pathologic features associated with cancer-specific survival
JC Cheville et al.
CANCER (2002)
Metastasis to bone: Causes, consequences and therapeutic opportunities
GR Mundy
NATURE REVIEWS CANCER (2002)
TGF-β signaling in tumor suppression and cancer progression
R Derynck et al.
NATURE GENETICS (2001)
Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.
MR Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer:: Detection and prognostic value
D Weckermann et al.
JOURNAL OF UROLOGY (2001)
Urokinase receptor and fibronectin regulate the ERKMAPK to p38MAPK activity ratios that determine carcinoma cell proliferation or dormancy in vivo
JA Aguirre-Ghiso et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Reciprocal regulation via protein-protein interaction between c-myc and p21cip1/waf1/sdi1 in DNA replication and transcription
H Kitaura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
